PTC Therapeutics PTCT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's operating lease ROU assets?
- PTC Therapeutics (PTCT) reported operating lease ROU assets of $76.69M in Q1 2026.
- How has PTC Therapeutics's operating lease ROU assets changed year-over-year?
- PTC Therapeutics's operating lease ROU assets increased by 33.8% year-over-year, from $57.32M to $76.69M.
- What is the long-term trend for PTC Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), PTC Therapeutics's operating lease ROU assets has grown at a -1.1% compound annual growth rate (CAGR), from $84.41M to $80.05M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.